In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples